BIOMARKER:

CD74-ROS1 fusion

Entrez ID:

Related biomarkers:

‹

›

CD74-ROS1 fusion CD74-ROS1 fusion	Malignant Pleural Mesothelioma Malignant Pleural Mesothelioma	CD74-ROS1 fusion CD74-ROS1 fusion	Malignant Pleural Mesothelioma Malignant Pleural Mesothelioma	crizotinib Sensitive: C4 – Case Studies J Cancer Res Clin Oncol - 3 weeks (New C4)	crizotinib Sensitive: C4 – Case Studies J Cancer Res Clin Oncol - 3 weeks - (New C4)
CD74-ROS1 fusion CD74-ROS1 fusion	Non Small Cell Lung Cancer NSCLC	CD74-ROS1 fusion CD74-ROS1 fusion	Non Small Cell Lung Cancer NSCLC	AB-106 Sensitive: C2 – Inclusion Criteria	AB-106 Sensitive: C2 – Inclusion Criteria
CD74-ROS1 fusion CD74-ROS1 fusion	Non Small Cell Lung Cancer NSCLC	CD74-ROS1 fusion CD74-ROS1 fusion	Non Small Cell Lung Cancer NSCLC	crizotinib Sensitive: C3 – Early Trials	crizotinib Sensitive: C3 – Early Trials
CD74-ROS1 fusion CD74-ROS1 fusion	Non Small Cell Lung Cancer NSCLC	CD74-ROS1 fusion CD74-ROS1 fusion	Non Small Cell Lung Cancer NSCLC	TPX-0005 Resistant: C4 – Case Studies	TPX-0005 Resistant: C4 – Case Studies
CD74-ROS1 fusion CD74-ROS1 fusion	Lung Adenocarcinoma LUAD	CD74-ROS1 fusion CD74-ROS1 fusion	Lung Adenocarcinoma LUAD	cisplatin + pemetrexed Sensitive: C4 – Case Studies	cisplatin + pemetrexed Sensitive: C4 – Case Studies
CD74-ROS1 fusion CD74-ROS1 fusion	Lung Adenocarcinoma LUAD	CD74-ROS1 fusion CD74-ROS1 fusion	Lung Adenocarcinoma LUAD	entrectinib Sensitive: C4 – Case Studies	entrectinib Sensitive: C4 – Case Studies
CD74-ROS1 fusion CD74-ROS1 fusion	Lung Cancer Lung Cancer	CD74-ROS1 fusion CD74-ROS1 fusion	Lung Cancer Lung Cancer	gilteritinib Sensitive: D – Preclinical	gilteritinib Sensitive: D – Preclinical